I’m with you on this. The sales team in the US has performed extremely well under difficult conditions over the past two years. And from what SR has said they are extremely energised and focused. I think that if hospital/ clinician access continues to improve that they will outperform the excellent growth obtained this last FY.
I’m with you on this. The sales team in the US has performed...
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.35 |
Change
0.020(0.86%) |
Mkt cap ! $1.623B | |||
| Open | High | Low | Value | Volume |
| $2.27 | $2.37 | $2.27 | $3.035M | 1.301M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 26580 | $2.35 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.37 | 12054 | 2 |
View Market Depth
| Last trade - 16.10pm 09/09/2024 (20 minute delay) ? |
| PNV (ASX) Chart |